Cannara Biotech Inc. (TSXV:LOVE)

Market Cap	120.56M
Revenue (ttm)	87.28M
Net Income (ttm)	6.64M
Shares Out	90.64M
EPS (ttm)	0.07
PE Ratio	18.04
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,700
Average Volume	45,019
Open	1.320
Previous Close	1.330
Day's Range	1.320 - 1.320
52-Week Range	0.520 - 1.460
Beta	1.07
RSI	52.66
Earnings Date	Jan 24, 2025

About Cannara Biotech

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2017
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: LOVE

Financial Performance

In 2024, Cannara Biotech's revenue was 81.75 million, an increase of 42.77% compared to the previous year's 57.26 million. Earnings were 6.44 million, a decrease of -7.30%.